Your browser doesn't support javascript.
loading
A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer.
Han, J Y; Nam, B H; Kim, H Y; Yoon, S J; Kim, H T; Lee, J S.
Afiliação
  • Han JY; Center for Lung Cancer; Center for Clinical Trial, Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.
  • Nam BH; Center for Clinical Trial, Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.
  • Kim HY; Center for Lung Cancer.
  • Yoon SJ; Center for Lung Cancer.
  • Kim HT; Center for Lung Cancer; Center for Clinical Trial, Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.
  • Lee JS; Center for Lung Cancer. Electronic address: jslee@ncc.re.kr.
Ann Oncol ; 23(11): 2925-2930, 2012 Nov.
Article em En | MEDLINE | ID: mdl-22782331

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Carcinoma Pulmonar de Células não Pequenas / Desoxicitidina / Fluoruracila / Dinitrato de Isossorbida / Neoplasias Pulmonares Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Camptotecina / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Carcinoma Pulmonar de Células não Pequenas / Desoxicitidina / Fluoruracila / Dinitrato de Isossorbida / Neoplasias Pulmonares Idioma: En Ano de publicação: 2012 Tipo de documento: Article